Publication: Coronavac covid-19 vaccine-induced anaphylaxis: Clinical characteristics and revaccination outcomes
0
0
Issued Date
2021
Resource Type
Language
eng
File Type
application/pdf
ISSN
11786965
Other identifier(s)
2-s2.0-85118542385
Rights Holder(s)
Scopus
Bibliographic Citation
Journal of Asthma and Allergy. Vol 14, No. (2021), p.1209-1215
Suggested Citation
Laisuan W., Wongsa C., Chiewchalermsri C., Thongngarm T., Rerkpattanapipat T., Iamrahong P., Ruangwattanachok C., Nanthapisal S., Sompornrattanaphan M. Coronavac covid-19 vaccine-induced anaphylaxis: Clinical characteristics and revaccination outcomes. Journal of Asthma and Allergy. Vol 14, No. (2021), p.1209-1215. doi:10.2147/JAA.S333098 Retrieved from: https://hdl.handle.net/20.500.14740/7961
Abstract
Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option. © 2021 Laisuan et al. This work is published and licensed by Dove Medical Press Limited.
Subject(s)
Coronavac
Immunoglobulin G
Inactivated vaccine
Adult
Anaphylaxis
Article
Burkholderia pseudomallei
Clinical article
Complement activation
Coronavirus disease 2019
Drug hypersensitivity
Fatigue
Female
Fever
Genetic variation
Headache
Human
Intensive care unit
Middle aged
Mortality
Myalgia
Nose polyp
Petechia
Prick test
Revaccination
Shellfish allergy
Treatment outcome
Vaccination
Immunoglobulin G
Inactivated vaccine
Adult
Anaphylaxis
Article
Burkholderia pseudomallei
Clinical article
Complement activation
Coronavirus disease 2019
Drug hypersensitivity
Fatigue
Female
Fever
Genetic variation
Headache
Human
Intensive care unit
Middle aged
Mortality
Myalgia
Nose polyp
Petechia
Prick test
Revaccination
Shellfish allergy
Treatment outcome
Vaccination